Cargando…
Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
BACKGROUND: The utilization of the Gustave Roussy Immune Score (GRIm-Score) in patient selection for immunotherapy was initially reported. The objective of this retrospective study is to assess the potential of the GRIm-Score, a novel prognostic score based on nutritional and inflammatory markers, a...
Autores principales: | Shangguan, Jian, Huang, Xinyi, Liu, Xu, Zhang, Zengfu, Zhang, Xiaodong, Yu, Jinming, Chen, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187137/ https://www.ncbi.nlm.nih.gov/pubmed/37205200 http://dx.doi.org/10.3389/fonc.2023.1195499 |
Ejemplares similares
-
Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis
por: Sun, Ke-Xin, et al.
Publicado: (2023) -
Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
por: Tian, Shan, et al.
Publicado: (2021) -
Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer
por: Shi, Yujing, et al.
Publicado: (2023) -
Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2020) -
Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
por: Minami, Seigo, et al.
Publicado: (2020)